Company / Depreciation & Amortization
ANAPTYSBIO, INC Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$559.0K
FY2025
5-year range
$514.0K / $652.0K
FY2021-FY2025
Trend
-7.8%
vs FY2024
Sector context
#131 of 168
Health Care
What the data says
ANAPTYSBIO, INC's depreciation & amortization of $559,000 is lower than 78% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $183,000 in FY2019 to $652,000 in FY2023.
Based on SEC 10-K filings.
$559,000 in FY2025 with a 5-year CAGR of +12.2%.
Improved from $652,000 to $559,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +12.2%
- 10-Year CAGR
- -
Sector benchmark
-99.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +12.2%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 7.8% year-over-year.
- Ranks #131 out of 168 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $559.0K | -7.8% |
| FY2024 | $606.0K | -7.1% |
| FY2023 | $652.0K | +16.6% |
| FY2022 | $559.0K | +8.8% |
| FY2021 | $514.0K | +63.2% |
| FY2020 | $315.0K | +72.1% |
| FY2019 | $183.0K | -41.9% |
| FY2018 | $315.0K | +15.0% |
| FY2017 | $274.0K | +17.6% |
| FY2016 | $233.0K | -15.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026